JAZZ Passer Band

K171881 · Implanet, S.A. · OWI · Aug 8, 2017 · Orthopedic

Device Facts

• Record ID: K171881
• Device Name: JAZZ Passer Band
• Applicant: Implanet, S.A.
• Product Code: OWI · Orthopedic
• Decision Date: Aug 8, 2017
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3010
• Device Class: Class 2
• Attributes: Therapeutic, Pediatric

Intended Use

The Jazz Systems are temporary implants to be used in orthopedic surgery. The Jazz Systems are intended to provide temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures. The indications for use include the following applications: - 1. Spinal trauma surgery, used in sublaminar or facet wiring techniques; - 2. Spinal reconstructive surgery, incorporated into constructs for the purpose of correction of spinal deformities such as adolescent idiopathic scoliosis, adult scoliosis, kyphosis and spondylolisthesis; - 3. Spinal degenerative surgery, as an adjunct to spinal fusions. The Jazz Systems may also be used in conjunction with other medical implants made of titanium alloy or cobalt-chromium-molybdenum allov whenever "wiring" may help secure the attachment of other implants.

Device Story

JAZZ Passer Band is a temporary orthopedic implant component of the JAZZ System; functions as a bone anchor for stabilization during bony fusion or fracture repair. Device consists of a braid with a buckle; used in spinal surgery to secure other implants (titanium or cobalt-chromium-molybdenum alloy) to the spine. Modification from predicate involves removing the distal metal strip and adding a hole to interface with new surgical instruments. Used by surgeons in clinical settings; provides mechanical stabilization to spinal constructs.

Clinical Evidence

Bench testing only. Static tensile testing was performed to evaluate the strength of the modified band extremity (the new interface hole) compared to the predicate.

Technological Characteristics

Temporary orthopedic bone fixation cerclage implant. Composed of braid with buckle. Modification involves removal of distal metal strip and addition of a hole for instrument interface. Mechanical principle of operation remains identical to predicate. No software or electronic components.

Indications for Use

Indicated for patients undergoing spinal trauma surgery (sublaminar/facet wiring), spinal reconstructive surgery (correction of deformities including adolescent idiopathic scoliosis, adult scoliosis, kyphosis, and spondylolisthesis), and spinal degenerative surgery (adjunct to spinal fusions).

Regulatory Classification

Identification

A bone fixation cerclage is a device intended to be implanted that is made of alloys, such as cobalt-chromium-molybdenum, and that consists of a metallic ribbon or flat sheet or a wire. The device is wrapped around the shaft of a long bone, anchored to the bone with wire or screws, and used in the fixation of fractures.

Predicate Devices

• Implanet's JAZZ Band (K170730)
• Implanet's JAZZ Frame (K162764)
• Implanet's JAZZ Lock (K153348)
• Implanet's JAZZ Claw (K160226)
• Implanet's Jazz Systems (K151740)

Submission Summary (Full Text)

{0}------------------------------------------------

August 8, 2017

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

Implanet, S.A. % Ms. Janice M. Hogan Partner Hogan Lovells US LLP 1835 Market Street, 29th Floor Philadelphia, Pennsylvania 19103

Re: K171881

Trade/Device Name: JAZZ Passer Band Regulation Number: 21 CFR 888.3010 Regulation Name: Bone fixation cerclage Regulatory Class: Class II Product Code: OWI Dated: June 23, 2017 Received: June 23, 2017

Dear Ms. Hogan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR

Image /page/0/Picture/10 description: The image is a circular seal for the Department of Health & Human Services - USA. The seal features the department's logo, which consists of a stylized caduceus with three human profiles. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the perimeter of the circle.

{1}------------------------------------------------

Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely.

# Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

510(k) Number (if known)

#### K171881

Device Name

JAZZ Passer Band Indications for Use (Describe)

The Jazz Systems are temporary implants to be used in orthopedic surgery. The Jazz Systems are intended to provide temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures.

The indications for use include the following applications:

- 1. Spinal trauma surgery, used in sublaminar or facet wiring techniques;
- 2. Spinal reconstructive surgery, incorporated into constructs for the purpose of correction of spinal deformities such as adolescent idiopathic scoliosis, adult scoliosis, kyphosis and spondylolisthesis;
- 3. Spinal degenerative surgery, as an adjunct to spinal fusions.

The Jazz Systems may also be used in conjunction with other medical implants made of titanium alloy or cobaltchromium-molybdenum allov whenever "wiring" may help secure the attachment of other implants.

Type of Use (Select one or both, as applicable)

区 Prescription Use (Part 21 CFR 801 Subpart D)

□ Over-The-Counter Use (21 CFR 801 Subpart C)

## CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

and a person is not required to respond to, a collection of "An agency may not conduct or sponsor, information unless it displays a currently valid OMB number."

{3}------------------------------------------------

## 510(k) SUMMARY Implanet's JAZZ System Including JAZZ Passer Band

#### Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared

lmplanet. S.A. Technopole Bordeaux Montesquieu Allée François Magendie 33650 Martillac France

Phone: [phone] Facsimile: [phone]

Contact Person: Regis Le Couedic, Director of Quality and Regulatory Affairs; Chief Technology Officer

Date Prepared: June 23, 2017

#### Application Correspondent:

Janice M. Hogan 1835 Market Street, 29th Floor Philadelphia, PA 19103 Phone: [phone]

## Name of Device

JAZZ Passer Band

## Common or Usual Name

Bone, Fixation, Cerclage, Sublaminar

#### Classification Name

Bone, Fixation, Cerclage

#### Primary Product Code

OWI

#### Regulation Number

21 CFR § 888.3010

{4}------------------------------------------------

## Device Class

Class II

## Predicate Devices

Implanet's JAZZ Band (K170730) (primary) Implanet's JAZZ Frame (K162764) (additional) Implanet's JAZZ Lock (K153348) (additional) lmplanet's JAZZ Claw (K160226) (additional) Implanet's Jazz Systems (K151740) (additional)

## Device Description

The Jazz Systems consists of the following components: JAZZ Connector, JAZZ Claw Connector, JAZZ Claw hooks, JAZZ Lock Connector, various rods, and JAZZ Braid (a.k.a. Band) with buckle. The JAZZ Band is inserted into various JAZZ connectors and is used to attach them to the spine.

## Intended Use/Indications for Use

The Jazz Systems are temporary implants to be used in orthopedic surgery. The Jazz Systems are intended to provide temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures.

The indications for use include the following applications:

- Spinal trauma surgery, used in sublaminar or facet wiring techniques; 4.
- 5. Spinal reconstructive surgery, incorporated into constructs for the purpose of correction of spinal deformities such as adolescent idiopathic scoliosis, adult scoliosis, kyphosis and spondvlolisthesis:
- 6. Spinal degenerative surgery, as an adjunct to spinal fusions.

The Jazz Systems may also be used in conjunction with other medical implants made of titanium alloy or cobalt-chromium-molybdenum alloy whenever "wiring" may help secure the attachment of other implants.

## Purpose of 510(k)

The purpose of this 510(k) is to modify the Jazz Band component of the Jazz Systems, renaming it the JAZZ Passer Band. The band is being modified to allow use of different surgical instruments.

## Technological Characteristics

The JAZZ Passer Band is identical to the predicate in terms of materials, overall dimensions, with only minor modifications to the manufacturing method. The two braids primarily differ in that the Passer Band does not have a distal metal strip for insertion and contains a small

{5}------------------------------------------------

hole for interfacing with the new surgical instruments. No changes are being made to other components in the JAZZ System.

#### Performance Data

These changes were assessed per static tensile testing to evaluate the strength of the hole at the band extremity.

#### Conclusions

The modified JAZZ Passer Band is as safe and effective as the predicate JAZZ Band. The JAZZ Passer Band has the same intended uses and indications, as well as similar technological characteristics and principles of operation as its predicate device. In addition, the minor technological differences between the JAZZ Passer Band and its predicate devices raise no new or different issues of safety or effectiveness. Performance data demonstrate that the modified JAZZ Passer Band is as safe and effective as the predicate JAZZ Band. Thus, the JAZZ Passer Band is substantially equivalent.